Latest News - DexCom
Top Corporates Hub
DexCom
DexCom Insiders Sold US$11m Of Shares Suggesting Hesitancy
25.08.2025 14:00
Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to the...
DexCom (NASDAQ:DXCM) Shareholders Will Want The ROCE Trajectory To Continue
21.08.2025 10:33
NasdaqGS:DXCM 1 Year Share Price vs Fair Value Explore DexCom's Fair Values from the Community and select yours If we...
FriskaAi and Dexcom Enter CGM Data Integration Agreement
13.08.2025 13:30
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 /FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the ...
DXCM Q2 CY2025 Deep Dive: Volume Growth, Leadership Changes, and New Product Launches Shape Outlook
13.08.2025 04:05
Medical device company DexCom (NASDAQ:DXCM) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s revenue to be around $4.61 billion, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 7.8% above analysts’ consensus estimates.
5 Revealing Analyst Questions From DexCom’s Q2 Earnings Call
13.08.2025 03:38
DexCom’s second quarter 2025 results saw the company surpass Wall Street’s revenue and earnings expectations, though the market’s immediate reaction was notably negative. Management attributed the quarter’s strong performance to sustained demand from both new and existing customers, with particular momentum among the type 2 non-insulin diabetes population. CEO Kevin Sayer emphasized DexCom’s expanding coverage through the three largest pharmacy benefit managers (PBMs), which now provides reimbur
Health Care Roundup: Market Talk
12.08.2025 10:20
Find insight on Novartis, Eli Lily, Dexcom and more in the latest Market Talks covering Health Care.
ViCentra to Bring Smartphone-Based Closed Loop Therapy to People with Diabetes in Early 2026
12.08.2025 07:30
ViCentra, maker of the Kaleido insulin patch pump, today announced that following the CE Mark approval of Diabeloop's DBLG2 algorithm under the EU Medical Device Regulation (MDR), its next-generation hybrid closed loop system is set to launch in Germany and the Netherlands in early 2026.
Inside Dexcom’s strategy to stay ahead in the $13.6bn CGM market
07.08.2025 09:39
With a new CEO taking over in 2026, Dexcom aims to stay ahead of its CGM competitors through a combination of innovation and product market expansion.
DexCom (DXCM) Extends Losses on Day 5 Amid Leadership Change
05.08.2025 17:06
We recently published 10 Stocks Bleeding Early. DexCom, Inc. (NASDAQ:DXCM) is one of the companies that stood stronger last week. DexCom fell for a fifth straight day on Monday, shedding 3.82 percent to close at $76.25 apiece as investors turned cautious following the announcement of a leadership change after the company’s strong earnings performance in the […]
Garmin announces collaborations with leading brands for Garmin Marathon Series
05.08.2025 11:03
Garmin (NYSE: GRMN) today announced Brooks, Dexcom, Maurten, Shokz and Therabody will support the Garmin Marathon Series with products and programming, beginning with the inaugural races in Toledo, Ohio on Sunday, Sept. 21.
DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise
31.07.2025 12:48
DXCM beats on Q2 earnings and raises 2025 sales guidance, but shares dip as margin pressure dampens investor enthusiasm.
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
29.07.2025 04:00
Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Earnings To Watch: DexCom (DXCM) Reports Q2 Results Tomorrow
29.07.2025 03:12
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Wednesday after market hours. Here’s what to look for.
Is DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 24% Impressive?
24.07.2025 14:00
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Is DexCom, Inc. (NASDAQ:DXCM) Trading At A 34% Discount?
18.07.2025 12:00
Key Insights The projected fair value for DexCom is US$127 based on 2 Stage Free Cash Flow to Equity DexCom is...
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
17.07.2025 12:30
SAN DIEGO, July 17, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company’s one-of-a-kind NIL (Name, Image and Likeness) program exclusively for college athletes with diabetes.
What You Need to Know Ahead of DexCom’s Earnings Release
07.07.2025 07:44
DexCom is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.
Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?
03.07.2025 13:40
Here is how DexCom (DXCM) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts
01.07.2025 18:41
The agency overseeing Medicare and Medicaid proposes $4.5 billion of spending cuts for home healthcare, and new economies on diabetes devices.
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
01.07.2025 16:20
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.